{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:51:13Z","timestamp":1791265873533,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) is a prevalent hematologic malignancy. A systematic comparison of the temporal trends in MM disease burden between China and the global level is important for optimizing prevention and control strategies. This study describes trends in the age\u2010 and sex\u2010specific burden of MM in China from 1990 to 2023, including incidence, prevalence, mortality, and disability\u2010adjusted life years (DALYs); projects sex\u2010specific incidence to 2050; and compares findings globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the Global Burden of Disease (GBD) 2023 database, we extracted data on MM in China and globally from 1990 to 2023. Joinpoint regression was used to calculate the average annual percentage change (AAPC) and its 95% confidence interval (CI) for trend analysis, with comprehensive comparisons by age and sex. In addition, Bayesian age\u2010period\u2010cohort (BAPC) modeling was used to describe and predict sex\u2010specific trends in MM incidence through 2050, with 95% uncertainty intervals (UIs) reported for GBD estimates and BAPC projections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2023, the age\u2010standardized incidence rate (ASIR) of MM increased from 0.30 to 0.94 per 100,000 people in China, and the global ASIR increased from 1.59 to 1.95 per 100,000. In China, the AAPC was 3.70%, well above the global level of 0.65%. Comparable differences were observed in prevalence, mortality, and DALYs. The burden of disease increased substantially with advancing age and was higher in males. The BAPC model suggested that by 2050, the ASIR for females in China may surpass that for males, whereas the global ASIR for both sexes is projected to continue to rise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The disease burden of MM in China has risen substantially faster than the global average over the past three decades and is expected to continue increasing, particularly among females. Priority public health strategies for prevention and control are essential to address this growing public health issue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cam4.72270","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:16Z","timestamp":1789455196000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Analysis of Multiple Myeloma Disease Burden in China and Globally From 1990 to 2023 and Future Trend Projections"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6521-6254","authenticated-orcid":false,"given":"Fuhong","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine The Eighth Affiliated Hospital, Sun Yat\u2010Sen University  Shenzhen China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The Eighth Affiliated Hospital, Sun Yat\u2010Sen University  Shenzhen China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30050334"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27422"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400712"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00005-X"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00529-7"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0141"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00698-x"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41223-8"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00877-9"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00165-X"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217440"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22688-2"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002600"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"e_1_2_13_17_1","volume-title":"Global Burden of Disease Results Tool, 2025","author":"Global Burden of Disease Collaborative Network","year":"2025"},{"key":"e_1_2_13_18_1","first-page":"45","volume-title":"Global Burden of Disease and Risk Factors","author":"Mathers C. D.","year":"2006"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31404-5"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201500263"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08280-y"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae321"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32040204"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01362-1"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-1950"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.04.003"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216035"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15748"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0389"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075437"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30427-1"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01290-y"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.044847"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003949"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280424"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01622-9"},{"key":"e_1_2_13_37_1","first-page":"253","article-title":"Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance","volume":"119","author":"Piechotta V.","year":"2022","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26747"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19716"},{"key":"e_1_2_13_40_1","first-page":"3280","article-title":"Bortezomib\u2010 and Carfilzomib\u2010Resistant Myeloma Cells Show Increased Activity of All Three Arms of the Unfolded Protein Response","volume":"12","author":"Kubicki T.","year":"2022","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.282905"},{"key":"e_1_2_13_42_1","unstructured":"National Center for Chronic and Noncommunicable Disease Control and Prevention Chinese Center for Disease Control and Prevention Cause\u2010of\u2010death surveillance datasets for China 2004\u20132021accessed at July 25 2026 https:\/\/ncncd.chinacdc.cn\/xzzq\/202606\/t20260605_1836532.htm."},{"key":"e_1_2_13_43_1","volume-title":"China Medium\u2010 and Long\u2010Term Plan for the Prevention and Treatment of Chronic Diseases (2017\u20102025), 2017","author":"General Office of the State Council of the People's Republic of China","year":"2017"},{"key":"e_1_2_13_44_1","unstructured":"National Health Commission of the People's Republic of China Healthy China Action (2019\u20132030)accessed at July 25 2026 https:\/\/www.nhc.gov.cn\/guihuaxxs\/c100133\/201907\/2a6ed52f1c264203b5351bdbbadd2da8.shtml."},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0284-7"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103508"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01990-1"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20175"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v021.i08"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.72270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.72270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.72270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:50:51Z","timestamp":1791262251000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.72270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/cam4.72270"],"URL":"https:\/\/doi.org\/10.1002\/cam4.72270","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72270"}}